Table Of ContentJournal of Surgical Oncology 2003;84:257-—258 
Author  Index  to Volume  84 
Adler,  Michael,  36  Fukai,  Yasuyuki, 24  Krogerus,  Leena Anneli, 68 
Adukia, Tarun  Kumar,  31  Fukuchi,  Minoru,  24  Kulaylat, Mahmoud  N., 178 
Adwani,  Asha,  105  Kunishima,  Satoshi,  74 
Ajisaka, Hideyuki,  89  Galandiuk,  Susan, 239  Kuriu,  Yoshiaki,  160 
Akasu, Takayuki,  127  Gelin,  Michel, 36, 215  Kute, Tim, 82 
Alzahrani,  Mohamed,  120  Gerrand, Craig H.,  198  Kuwano,  Hiroyuki, 24 
Anderson, Timothy  M., 234  Goldman,  Serge, 215 
Arthur,  Douglas,  185  Griffin,  Anthony M.,  198  Law, Calvin  H. L.,  120 
Asao, Takayuki,  24  Gross, Allan E., 198  Lawrence,  Walter, Jr., 44, 53 
Lee, Ji Shin,  166 
Bae, Jae Moon, 50  Habuchi, Tomonori,  209  Lee, Jun Ho, 50 
Bear,  Harry  D., 53, 57  Hagiwara, Akeo,  160  Lee, Min Cheol,  166 
Bell, Robert  S.,  198  Hanna,  Sherif S., 120  Leidenius,  Marjut Hannele  Kristiina, 
Bertagnolli,  Monica  M.,  113  Hansma,  Annemarie  H. G.,  137  68 
Bhutani,  Manisha,  192  Hawkins,  Nicholas J., 143  Lequaglie, Cosimo,  249 
Boelens,  Petra G.,  137  Hiraoka,  Kei, 224  Levine,  Edward  A., 82 
Boon,  Nathalie,  36  Hoekman,  Klaas,  137  Lin, Chin-Tang,  17 
Botti, Gerardo,  229  Huang, Su-Cheng,  17  Lingier, Pierre, 36 
Bourgeois,  Nadine,  36  Litwin,  Alan  M., 234 
Brega-Massone,  Pier Paolo, 249  Ichikawa,  Daisuke,  160  Loewen, Gregory  M., 234 
Ickx,  Brigitte, 36, 215  Lowe, Susan,  105 
Ikeda, Tadashi,  173 
Caraco, Corrado,  229 
Inman, J. Lucas, 82  Magnani,  Barbara,  249 
Cassel, Jay Brian, 57 
Itoh, Tomoo,  224  Manda,  Ryokuhei,  24 
Cataldo,  Ignazio, 249 
Iwahashi,  Makoto,  10  Masuda,  Norihiro,  24 
Chan, Wing-Yee,  17 
Matsumura,  Hiroomi,  160 
Chaturvedi,  Pankaj,  103, 255 
Jinno,  Hiromitsu,  173  Meagher,  Alan  P., 143 
Chaukar,  Devendra  A.,  103 
Meijer, Catharina,  137 
Closset, Jean, 36 
Kaminska,  Janina,  151  Meijer, Sybren,  137 
Colliver,  Daniel  W., 239 
Kamoto, Toshiyuki, 209  Mishra, Chandra  Pati, 31 
Crawford,  Nigel P. S., 239 
Kanitkar, Gajanan, 255  Mishra,  Ravindra  Nath, 31 
Cuesta,  Miguel A.,  137 
Kaplan,  Brian J., 57  Miwa,  Koichi,  89 
Karakousis, Constantine  P., 178  Miyamoto,  Masaki,  224 
D’Cruz,  Anil  K., 255  Karp, Stephen E., 57  Miyazaki, Tatsuya, 24 
Davis,  Aileen  M.,  198  Kato, Hiroyuki, 24  Moriya, Yoshihiro,  127 
Decruz,  Anil  K.,  103  Katoh,  Hiroyuki, 224  Morrow,  Monica,  55 
Deo, S. V. S., 192  Khalifa,  Mahmoud,  120  Mozzillo,  Nicola,  229 
Deshpande,  Mandar S.,  103  Kim, Hyung Seok,  166  Mulshine, James L.,  | 
Donckier,  Vincent,  36, 215  Kim, Young Bok,  166 
Kim,  Young Woo, 50  Nakajima,  Masanobu,  24 
Eguchi, Teruo,  132  Kitagawa,  Yuko,  173  Nakakubo,  Yoshihiro,  224 
E] Nakadi,  Issam, 36  Kitajima,  Masaki,  173  Nakamori,  Mikihito,  10 
Fazioli,  Flavio,  229  Klippenstein,  Donald L., 234  Nakamura,  Masaki,  10 
Feron,  Pascale,  36, 215  Kobayashi, Takashi,  209  Neifeld, James P., 57 
Froix,  Anthony J., 7  Koh, Toshimori,  74  Noguchi,  Masakuni,  94 
Fujii, Masashi,  132  Kondo,  Satoshi,  224  Norrie,  Mark W. A.,  143 
Fujita, Shin,  127  Kowalska,  Maria,  151  Nunziata, Carmine  A., 229 
257
258  Author  Index 
O’Connor,  Terence  W.,  |  Salti, George  I., 7  Torng, Pao-Ling,  17 
Ogawa, Osamu,  209  Sampath, S.,  176  Tsukada,  Katsuhiko,  24 
Ojima,  Hitoshi,  24  Sauter,  Edward  R.,  102 
Okamoto,  Kazuma,  160  Scotté,  Michel,  137  van  de Velde, Cornelis d 
Oshikiri,  Taro,  224  Shetty, Shishir,  103  Van Gansbeke,  Daniel,3  
Otsuji, Eigo,  160  Shichinohe,  Toshiaki,  224  Van Laethem,  Jean  Luc, rv2,  13 
Shimoda,  Tadakazu,  127  van  Leeuwen,  Paul  A. M.,  137 
Pai, Prathamesh  S.,  103,  255  Shinohara,  Toshiya, 224  Vazquez,  Vinicius de ae 45 
Park, Chang Soo,  166  Shukla,  Nootan  K.,  192  von  Smitten,  Karl Johan  Albert, 
Parviz,  Maryam,  57  Shukla,  Vijay  Kumar,  31  68 
Pathak,  Kumar  A.,  103  Singh, Sureshwer  Prasad,  31 
Peeters,  Koen  C.  M. J.,  10  Smith,  Andrew  J., 120  Ward,  Robyn L.,  143 
Peintinger,  Florentia,  63  Sohda,  Makoto,  24  Warner,  Elizabeth  E.,  | 
Penberthy,  Lynne T., 57  Steffen,  Jan,  151  Wells,  Samuel  A., Jr., 
Pettenati,  Mark,  82  Sugarbaker,  Paul  H., 45  White, Wain,  82 
Prabhudesai,  Shirish  G.,  25  Sugino,  Yoshio,  209  Wiezer,  Marinus  J.,  137 
Prokop, Eva, 63  Suzuoki,  Masato,  224  Wikler,  David,  215 
Purkayasth,  Joydeep,  192  Wilkinson,  Neal  W., 234 
Takayama, Tadatoshi,  |  Wright, Frances C.,  120 
Raina,  Vinod,  192  Takeuchi,  Hideo,  209  Wu, Francis  P. K.,  137 
Rapanos, Theodore,  120  Takita,  Junko,  24  Wunder,  Jay S.,  198 
Rath, Goura  K.,  192  Taniguchi,  Hiroki,  74 
Reitsamer,  Roland,  63  Temple, C. L. F., 176  Yamagishi,  Hisakazu,  74,  160 
Rettenbacher,  Lukas,  63  Temple,  W. J., 176  Yamaguchi,  Akihiro,  74 
Ruka,  Wlodzimierz,  151  Todd,  Alison  V.,  143  Yamamoto,  Seiichiro,  127 
Rutkowski,  Piotr,  151  Toivonen,  Terttu  Sinikka,  68  Yamaue,  Hiroki,  10 
Ryu, Keun Won, 50  Toma,  Atsushi,  160  Yoshimura,  Kimio,  127
Journal of Surgical Oncology  2003:84:259-260 
Subject  Index  to Volume  84 
5-fluorouracil,  10  fluorescence  bronchoscopy,  234  micrometastases,  68,  120 
fluoro-deoxyglucose,  74  micronutrients,  31 
allograft,  198  focal dedifferentiation,  127  microsatellite  instability,  143 
angiogenesis,  137  fracture,  198  minichromosome  maintenance 
antioxidants,  31  frozen  section, 68  protein  2 (MCM2),  24 
apoptosis,  166  minimally  invasive  surgery, 94 
axillary  lymph node dissection,  63  gallbladder cancer,  74  molecular  markers,  234 
axillary  metastases,  68  gallbladder carcinoma,  31  monoclonal  antibody  A7,  160 
gallbladder tumor,  74  morbidity,  132 
bone,  15]  gastric cancer,  50  MTT assay,  10 
breast cancer,  63, 94  mucosa,  103 
breast conservation  therapy, 57  half-time,  160 
hepatic, 215  neoadjuvant  chemotherapy,  63,  192 
cancer  screening,  239  hepatocellular carcinoma,  89  neoplastic  invasion,  209 
cancer  stage,  132  HER2, 82  non-union,  198 
cancer  vaccines,  239  Herceptin “ ,  82 
carcinoembryonic  antigen, 239  human  papillomavirus,  17  oncological  patients,  249 
carcinoma,  36  oral cancer,  103 
cause  of death,  132  immunohistochemistry,  24, 68,  143,  outcome,  132 
cell proliferation,  166  224 
cervical  intraepithelial  neoplasia,  17  imprint cytology, 68  pathology,  120 
chest  X-ray, 234  infection,  198  perineural  invasion,  127 
chimeric  antibody,  160  interleukin-6,  137  peritoneal  carcinomatosis,  45 
cirrhosis,  36  intratumoral  CD8*  T cell, 224  peritonectomy, 45 
cisplatin,  10  peritonectomy  procedure, 45 
colorectal  cancer,  127,  143, 239  keratoderma  palmoplantaris,  229  poor prognosis,  132 
computed tomography,  234  Ki-67, 24  positron emission  tomography,  74 
curative  surgery,  120  postoperative chemotherapy,  10 
cystectomy,  209  laparoscope, 50  preoperative diagnosis,  209 
cytokine,  15]  lip melanoma,  7  prognosis,  151 
cytoreductive  surgery, 45  liver resection,  137  prognostic  factor,  7, 127, 224 
local,  215  prognostic  value,  24 
destruction,  215  locally  advanced  breast cancer  protein induced  by vitamin  K 
diagnostic  imaging,  160  (LABC),  192  absence  or antagonist  II, 89 
lung cancer,  234  PTEN,  166 
early  stage breast cancer,  57  lymphovascular  invasion,  120 
electrosurgery, 45  radiation  therapy, 57 
endostatin,  137  Mal de Meleda,  229  radiofrequency  ablation,  36, 94 
esophageal  cancer,  10  malignancy,  215  radioimmunoscintigraphy,  160 
esophageal carcinoma,  24  malignant  melanoma,  229  recessive  transgressive palmoplantar 
evaluation,  215  median  sternotomy,  249  keratoderma,  229 
extrahepatic  bile duct carcinoma,  medical  insurance,  57  recombinant  bactericidal/ 
224  MEDIZIP™,  249  permeability-increasing  protein 
extremely elderly,  132  metastasis,  82  (rBPI,,),  137 
methylation,  143  reconstruction,  103 
Fab fragment,  160  methylation-specific  PCR,  143  renal cell carcinoma,  166 
FDG-PET,  74  methylmethacrylate,  198  resection,  36 
259
260  Subject  Index 
sarcoma,  151,  198  staging, 50,  120  tumor aggressiveness,  24 
screening,  234  streak  type,  127  tumor  markers,  239 
self-retaining  retractor,  45  survival,  120,  192 
sentinel  lymph node biopsy,  ,  — 
;  ihe  :  '  uterine  cervix,  17 
single port, 50  transforming  growth factor receptor, 
skin graft,  103  17 
skin-closure  system,  249  transforming  growth factor  B, 17  vascular  infiltration,  89 
sputum cytology,  234  transplantation,  36  VEGF,  137